New patent for Alnylam Pharms drug ONPATTRO

Annual Drug Patent Expirations for ONPATTRO Onpattro is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twenty-one patents protecting this drug. Drug patent…

The post New patent for Alnylam Pharms drug ONPATTRO appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog